IMS Health Holdings, Inc. (NYSE: IMS) Stock Competitors & Peer Comparison
See IMS's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for IMS and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| IMS | $31.34 | +0.00% | 0 | N/A | N/A | N/A |
| GEHC | $72.28 | -0.65% | 32.6B | 15.85 | $4.56 | +0.19% |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| BTSG | $59.68 | +3.09% | 11.7B | 48.13 | $1.24 | N/A |
| TEM | $54.61 | -1.94% | 9.6B | -109.22 | -$0.50 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| HQY | $105.50 | -0.07% | 8.8B | 24.65 | $4.28 | N/A |
| TXG | $57.75 | -1.25% | 7.3B | -339.71 | -$0.17 | N/A |
| HNGE | $86.32 | -3.02% | 6.7B | 46.19 | $1.87 | N/A |
| RCM | $14.31 | N/A | 6B | -102.21 | -$0.14 | N/A |
Stock Comparison
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
IMS vs GEHC Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, GEHC has a market cap of 32.6B. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while GEHC trades at $72.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas GEHC's P/E ratio is 15.85. In terms of profitability, IMS's ROE is +0.27%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, IMS is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for IMS.Check GEHC's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
IMS vs GEHCV Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas GEHCV's P/E ratio is N/A. In terms of profitability, IMS's ROE is +0.27%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, IMS is less volatile compared to GEHCV. This indicates lower risk in terms of short-term price fluctuations for IMS.Check GEHCV's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
IMS vs BTSG Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, BTSG has a market cap of 11.7B. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while BTSG trades at $59.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas BTSG's P/E ratio is 48.13. In terms of profitability, IMS's ROE is +0.27%, compared to BTSG's ROE of +0.15%. Regarding short-term risk, IMS is less volatile compared to BTSG. This indicates lower risk in terms of short-term price fluctuations for IMS.Check BTSG's competition here
Tempus AI, Inc. (NASDAQ: TEM)
IMS vs TEM Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, TEM has a market cap of 9.6B. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while TEM trades at $54.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas TEM's P/E ratio is -109.22. In terms of profitability, IMS's ROE is +0.27%, compared to TEM's ROE of -0.55%. Regarding short-term risk, IMS is less volatile compared to TEM. This indicates lower risk in terms of short-term price fluctuations for IMS.Check TEM's competition here
Signify Health, Inc. (NYSE: SGFY)
IMS vs SGFY Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas SGFY's P/E ratio is 70.91. In terms of profitability, IMS's ROE is +0.27%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, IMS is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for IMS.Check SGFY's competition here
HealthEquity, Inc. (NASDAQ: HQY)
IMS vs HQY Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, HQY has a market cap of 8.8B. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while HQY trades at $105.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas HQY's P/E ratio is 24.65. In terms of profitability, IMS's ROE is +0.27%, compared to HQY's ROE of +0.11%. Regarding short-term risk, IMS is less volatile compared to HQY. This indicates lower risk in terms of short-term price fluctuations for IMS.Check HQY's competition here
10x Genomics, Inc. (NASDAQ: TXG)
IMS vs TXG Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, TXG has a market cap of 7.3B. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while TXG trades at $57.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas TXG's P/E ratio is -339.71. In terms of profitability, IMS's ROE is +0.27%, compared to TXG's ROE of -0.09%. Regarding short-term risk, IMS is less volatile compared to TXG. This indicates lower risk in terms of short-term price fluctuations for IMS.Check TXG's competition here
Hinge Health, Inc. (NYSE: HNGE)
IMS vs HNGE Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, HNGE has a market cap of 6.7B. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while HNGE trades at $86.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas HNGE's P/E ratio is 46.19. In terms of profitability, IMS's ROE is +0.27%, compared to HNGE's ROE of +0.30%. Regarding short-term risk, IMS is less volatile compared to HNGE. This indicates lower risk in terms of short-term price fluctuations for IMS.Check HNGE's competition here
R1 RCM Inc. (NASDAQ: RCM)
IMS vs RCM Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, RCM has a market cap of 6B. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas RCM's P/E ratio is -102.21. In terms of profitability, IMS's ROE is +0.27%, compared to RCM's ROE of +0.00%. Regarding short-term risk, IMS is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for IMS.Check RCM's competition here
Waystar Holding Corp. (NASDAQ: WAY)
IMS vs WAY Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, WAY has a market cap of 4.7B. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while WAY trades at $24.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas WAY's P/E ratio is 16.25. In terms of profitability, IMS's ROE is +0.27%, compared to WAY's ROE of +0.04%. Regarding short-term risk, IMS is less volatile compared to WAY. This indicates lower risk in terms of short-term price fluctuations for IMS.Check WAY's competition here
Doximity, Inc. (NYSE: DOCS)
IMS vs DOCS Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, DOCS has a market cap of 4.7B. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while DOCS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas DOCS's P/E ratio is 16.33. In terms of profitability, IMS's ROE is +0.27%, compared to DOCS's ROE of +0.17%. Regarding short-term risk, IMS is less volatile compared to DOCS. This indicates lower risk in terms of short-term price fluctuations for IMS.Check DOCS's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
IMS vs ONEM Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas ONEM's P/E ratio is -7.77. In terms of profitability, IMS's ROE is +0.27%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, IMS is less volatile compared to ONEM. This indicates lower risk in terms of short-term price fluctuations for IMS.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
IMS vs PRVA Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, PRVA has a market cap of 2.7B. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while PRVA trades at $21.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas PRVA's P/E ratio is 102.57. In terms of profitability, IMS's ROE is +0.27%, compared to PRVA's ROE of +0.00%. Regarding short-term risk, IMS is less volatile compared to PRVA. This indicates lower risk in terms of short-term price fluctuations for IMS.Check PRVA's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
IMS vs HTFL Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, HTFL has a market cap of 2.6B. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while HTFL trades at $29.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas HTFL's P/E ratio is -14.85. In terms of profitability, IMS's ROE is +0.27%, compared to HTFL's ROE of +8.30%. Regarding short-term risk, IMS is less volatile compared to HTFL. This indicates lower risk in terms of short-term price fluctuations for IMS.Check HTFL's competition here
GeneDx Holdings Corp. (NASDAQ: WGS)
IMS vs WGS Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, WGS has a market cap of 2.5B. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while WGS trades at $82.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas WGS's P/E ratio is 228.86. In terms of profitability, IMS's ROE is +0.27%, compared to WGS's ROE of -0.39%. Regarding short-term risk, IMS is more volatile compared to WGS. This indicates higher risk in terms of short-term price fluctuations for IMS.Check WGS's competition here
Progyny, Inc. (NASDAQ: PGNY)
IMS vs PGNY Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, PGNY has a market cap of 2B. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while PGNY trades at $25.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas PGNY's P/E ratio is 18.42. In terms of profitability, IMS's ROE is +0.27%, compared to PGNY's ROE of +0.16%. Regarding short-term risk, IMS is less volatile compared to PGNY. This indicates lower risk in terms of short-term price fluctuations for IMS.Check PGNY's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
IMS vs NXGN Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas NXGN's P/E ratio is -266.00. In terms of profitability, IMS's ROE is +0.27%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, IMS is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for IMS.Check NXGN's competition here
Omada Health (NASDAQ: OMDA)
IMS vs OMDA Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, OMDA has a market cap of 1.4B. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while OMDA trades at $23.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas OMDA's P/E ratio is 340.57. In terms of profitability, IMS's ROE is +0.27%, compared to OMDA's ROE of +0.02%. Regarding short-term risk, IMS is more volatile compared to OMDA. This indicates higher risk in terms of short-term price fluctuations for IMS.Check OMDA's competition here
Agiliti, Inc. (NYSE: AGTI)
IMS vs AGTI Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas AGTI's P/E ratio is -71.79. In terms of profitability, IMS's ROE is +0.27%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, IMS is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for IMS.Check AGTI's competition here
Certara, Inc. (NASDAQ: CERT)
IMS vs CERT Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, CERT has a market cap of 1.2B. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while CERT trades at $8.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas CERT's P/E ratio is 20.02. In terms of profitability, IMS's ROE is +0.27%, compared to CERT's ROE of -0.07%. Regarding short-term risk, IMS is more volatile compared to CERT. This indicates higher risk in terms of short-term price fluctuations for IMS.Check CERT's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
IMS vs GDRX Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, GDRX has a market cap of 1.2B. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while GDRX trades at $3.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas GDRX's P/E ratio is 11.22. In terms of profitability, IMS's ROE is +0.27%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, IMS is less volatile compared to GDRX. This indicates lower risk in terms of short-term price fluctuations for IMS.Check GDRX's competition here
Teladoc Health, Inc. (NYSE: TDOC)
IMS vs TDOC Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, TDOC has a market cap of 1.2B. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while TDOC trades at $6.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas TDOC's P/E ratio is -7.44. In terms of profitability, IMS's ROE is +0.27%, compared to TDOC's ROE of -0.13%. Regarding short-term risk, IMS is less volatile compared to TDOC. This indicates lower risk in terms of short-term price fluctuations for IMS.Check TDOC's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
IMS vs CCLDO Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas CCLDO's P/E ratio is N/A. In terms of profitability, IMS's ROE is +0.27%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, IMS is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for IMS.Check CCLDO's competition here
HealthStream, Inc. (NASDAQ: HSTM)
IMS vs HSTM Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, HSTM has a market cap of 828.5M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while HSTM trades at $28.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas HSTM's P/E ratio is 35.01. In terms of profitability, IMS's ROE is +0.27%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, IMS is more volatile compared to HSTM. This indicates higher risk in terms of short-term price fluctuations for IMS.Check HSTM's competition here
Phreesia, Inc. (NYSE: PHR)
IMS vs PHR Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, PHR has a market cap of 757.8M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while PHR trades at $12.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas PHR's P/E ratio is 43.79. In terms of profitability, IMS's ROE is +0.27%, compared to PHR's ROE of +0.03%. Regarding short-term risk, IMS is more volatile compared to PHR. This indicates higher risk in terms of short-term price fluctuations for IMS.Check PHR's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
IMS vs SOPH Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, SOPH has a market cap of 635.1M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while SOPH trades at $7.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas SOPH's P/E ratio is -6.82. In terms of profitability, IMS's ROE is +0.27%, compared to SOPH's ROE of -1.37%. Regarding short-term risk, IMS is more volatile compared to SOPH. This indicates higher risk in terms of short-term price fluctuations for IMS.Check SOPH's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
IMS vs MPLN-WT Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, IMS's ROE is +0.27%, compared to MPLN-WT's ROE of +1.40%. Regarding short-term risk, IMS is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for IMS.Check MPLN-WT's competition here
Claritev Corporation (NYSE: CTEV)
IMS vs CTEV Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, CTEV has a market cap of 596M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while CTEV trades at $35.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas CTEV's P/E ratio is -2.06. In terms of profitability, IMS's ROE is +0.27%, compared to CTEV's ROE of +1.40%. Regarding short-term risk, IMS is less volatile compared to CTEV. This indicates lower risk in terms of short-term price fluctuations for IMS.Check CTEV's competition here
Accolade, Inc. (NASDAQ: ACCD)
IMS vs ACCD Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas ACCD's P/E ratio is -3.08. In terms of profitability, IMS's ROE is +0.27%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, IMS is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for IMS.Check ACCD's competition here
Sharecare, Inc. (NASDAQ: SHCR)
IMS vs SHCR Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas SHCR's P/E ratio is -3.76. In terms of profitability, IMS's ROE is +0.27%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, IMS is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for IMS.Check SHCR's competition here
Evolent Health, Inc. (NYSE: EVH)
IMS vs EVH Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, EVH has a market cap of 469.6M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while EVH trades at $4.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas EVH's P/E ratio is 32.12. In terms of profitability, IMS's ROE is +0.27%, compared to EVH's ROE of -0.99%. Regarding short-term risk, IMS is less volatile compared to EVH. This indicates lower risk in terms of short-term price fluctuations for IMS.Check EVH's competition here
NRC Health (NASDAQ: NRC)
IMS vs NRC Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, NRC has a market cap of 464.5M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while NRC trades at $20.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas NRC's P/E ratio is 25.13. In terms of profitability, IMS's ROE is +0.27%, compared to NRC's ROE of +0.48%. Regarding short-term risk, IMS is less volatile compared to NRC. This indicates lower risk in terms of short-term price fluctuations for IMS.Check NRC's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
IMS vs SLGC Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas SLGC's P/E ratio is -3.04. In terms of profitability, IMS's ROE is +0.27%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, IMS is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for IMS.Check SLGC's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
IMS vs SLGCW Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, IMS's ROE is +0.27%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, IMS is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for IMS.Check SLGCW's competition here
TruBridge, Inc. (NASDAQ: TBRG)
IMS vs TBRG Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas TBRG's P/E ratio is 9.37. In terms of profitability, IMS's ROE is +0.27%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, IMS is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for IMS.Check TBRG's competition here
MultiPlan Corporation (NYSE: MPLN)
IMS vs MPLN Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas MPLN's P/E ratio is -0.23. In terms of profitability, IMS's ROE is +0.27%, compared to MPLN's ROE of +1.40%. Regarding short-term risk, IMS is less volatile compared to MPLN. This indicates lower risk in terms of short-term price fluctuations for IMS.Check MPLN's competition here
So-Young International Inc. (NASDAQ: SY)
IMS vs SY Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, SY has a market cap of 295.2M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while SY trades at $2.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas SY's P/E ratio is -6.82. In terms of profitability, IMS's ROE is +0.27%, compared to SY's ROE of -0.16%. Regarding short-term risk, IMS is less volatile compared to SY. This indicates lower risk in terms of short-term price fluctuations for IMS.Check SY's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
IMS vs TRHC Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas TRHC's P/E ratio is -4.27. In terms of profitability, IMS's ROE is +0.27%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, IMS is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for IMS.Check TRHC's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
IMS vs SMFR Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas SMFR's P/E ratio is N/A. In terms of profitability, IMS's ROE is +0.27%, compared to SMFR's ROE of -0.39%. Regarding short-term risk, IMS is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for IMS.Check SMFR's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
IMS vs SPOK Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, SPOK has a market cap of 229.3M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while SPOK trades at $10.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas SPOK's P/E ratio is 18.30. In terms of profitability, IMS's ROE is +0.27%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, IMS is less volatile compared to SPOK. This indicates lower risk in terms of short-term price fluctuations for IMS.Check SPOK's competition here
American Well Corporation (NYSE: AMWL)
IMS vs AMWL Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, AMWL has a market cap of 214.8M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while AMWL trades at $12.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas AMWL's P/E ratio is -2.86. In terms of profitability, IMS's ROE is +0.27%, compared to AMWL's ROE of -0.33%. Regarding short-term risk, IMS is less volatile compared to AMWL. This indicates lower risk in terms of short-term price fluctuations for IMS.Check AMWL's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
IMS vs CPSI Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas CPSI's P/E ratio is -183.80. In terms of profitability, IMS's ROE is +0.27%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, IMS is less volatile compared to CPSI. This indicates lower risk in terms of short-term price fluctuations for IMS.Check CPSI's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
IMS vs HCAT Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, HCAT has a market cap of 132.3M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while HCAT trades at $1.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas HCAT's P/E ratio is 8.95. In terms of profitability, IMS's ROE is +0.27%, compared to HCAT's ROE of -1.30%. Regarding short-term risk, IMS is less volatile compared to HCAT. This indicates lower risk in terms of short-term price fluctuations for IMS.Check HCAT's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
IMS vs OPRX Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, OPRX has a market cap of 132.1M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while OPRX trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas OPRX's P/E ratio is 6.46. In terms of profitability, IMS's ROE is +0.27%, compared to OPRX's ROE of +0.05%. Regarding short-term risk, IMS is less volatile compared to OPRX. This indicates lower risk in terms of short-term price fluctuations for IMS.Check OPRX's competition here
Augmedix, Inc. (NASDAQ: AUGX)
IMS vs AUGX Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas AUGX's P/E ratio is -4.99. In terms of profitability, IMS's ROE is +0.27%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, IMS is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for IMS.Check AUGX's competition here
CareCloud, Inc. (NASDAQ: CCLD)
IMS vs CCLD Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, CCLD has a market cap of 104.1M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while CCLD trades at $2.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas CCLD's P/E ratio is 9.42. In terms of profitability, IMS's ROE is +0.27%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, IMS is less volatile compared to CCLD. This indicates lower risk in terms of short-term price fluctuations for IMS.Check CCLD's competition here
SCWorx Corp. (NASDAQ: WORX)
IMS vs WORX Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, WORX has a market cap of 88M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while WORX trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas WORX's P/E ratio is -6.40. In terms of profitability, IMS's ROE is +0.27%, compared to WORX's ROE of -0.65%. Regarding short-term risk, IMS is less volatile compared to WORX. This indicates lower risk in terms of short-term price fluctuations for IMS.Check WORX's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
IMS vs DH Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, DH has a market cap of 68.6M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while DH trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas DH's P/E ratio is 2.50. In terms of profitability, IMS's ROE is +0.27%, compared to DH's ROE of -0.75%. Regarding short-term risk, IMS is less volatile compared to DH. This indicates lower risk in terms of short-term price fluctuations for IMS.Check DH's competition here
Forian Inc. (NASDAQ: FORA)
IMS vs FORA Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas FORA's P/E ratio is -24.11. In terms of profitability, IMS's ROE is +0.27%, compared to FORA's ROE of -0.17%. Regarding short-term risk, IMS is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for IMS.Check FORA's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
IMS vs CCLDP Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas CCLDP's P/E ratio is N/A. In terms of profitability, IMS's ROE is +0.27%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, IMS is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for IMS.Check CCLDP's competition here
OneMedNet Corporation (NASDAQ: ONMD)
IMS vs ONMD Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, ONMD has a market cap of 42.1M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while ONMD trades at $0.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas ONMD's P/E ratio is -4.92. In terms of profitability, IMS's ROE is +0.27%, compared to ONMD's ROE of +0.90%. Regarding short-term risk, IMS is less volatile compared to ONMD. This indicates lower risk in terms of short-term price fluctuations for IMS.Check ONMD's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
IMS vs SNCE Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas SNCE's P/E ratio is -0.27. In terms of profitability, IMS's ROE is +0.27%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, IMS is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for IMS.Check SNCE's competition here
Akili, Inc. (NASDAQ: AKLI)
IMS vs AKLI Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas AKLI's P/E ratio is -0.71. In terms of profitability, IMS's ROE is +0.27%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, IMS is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for IMS.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
IMS vs SHLT Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas SHLT's P/E ratio is -3.87. In terms of profitability, IMS's ROE is +0.27%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, IMS is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for IMS.Check SHLT's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
IMS vs SHCRW Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, IMS's ROE is +0.27%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, IMS is less volatile compared to SHCRW. This indicates lower risk in terms of short-term price fluctuations for IMS.Check SHCRW's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
IMS vs ONMDW Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, ONMDW has a market cap of 32M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while ONMDW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas ONMDW's P/E ratio is N/A. In terms of profitability, IMS's ROE is +0.27%, compared to ONMDW's ROE of +0.90%. Regarding short-term risk, IMS is less volatile compared to ONMDW. This indicates lower risk in terms of short-term price fluctuations for IMS.Check ONMDW's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
IMS vs STRM Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas STRM's P/E ratio is -2.40. In terms of profitability, IMS's ROE is +0.27%, compared to STRM's ROE of -0.65%. Regarding short-term risk, IMS is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for IMS.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
IMS vs RNLX Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas RNLX's P/E ratio is -0.33. In terms of profitability, IMS's ROE is +0.27%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, IMS is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for IMS.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
IMS vs LIFW Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas LIFW's P/E ratio is -0.02. In terms of profitability, IMS's ROE is +0.27%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, IMS is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for IMS.Check LIFW's competition here
Scienture Holdings, Inc. (NASDAQ: SCNX)
IMS vs SCNX Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, SCNX has a market cap of 17.8M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while SCNX trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas SCNX's P/E ratio is -0.17. In terms of profitability, IMS's ROE is +0.27%, compared to SCNX's ROE of -0.00%. Regarding short-term risk, IMS is less volatile compared to SCNX. This indicates lower risk in terms of short-term price fluctuations for IMS.Check SCNX's competition here
Babylon Holdings Limited (NYSE: BBLN)
IMS vs BBLN Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas BBLN's P/E ratio is -0.04. In terms of profitability, IMS's ROE is +0.27%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, IMS is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for IMS.Check BBLN's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
IMS vs BEATW Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, BEATW has a market cap of 13M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while BEATW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas BEATW's P/E ratio is -0.03. In terms of profitability, IMS's ROE is +0.27%, compared to BEATW's ROE of -10.34%. Regarding short-term risk, IMS is less volatile compared to BEATW. This indicates lower risk in terms of short-term price fluctuations for IMS.Check BEATW's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
IMS vs BFRG Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, BFRG has a market cap of 10.8M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while BFRG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas BFRG's P/E ratio is -1.07. In terms of profitability, IMS's ROE is +0.27%, compared to BFRG's ROE of -2.18%. Regarding short-term risk, IMS is less volatile compared to BFRG. This indicates lower risk in terms of short-term price fluctuations for IMS.Check BFRG's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
IMS vs ETAO Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas ETAO's P/E ratio is -0.01. In terms of profitability, IMS's ROE is +0.27%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, IMS is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for IMS.Check ETAO's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
IMS vs MGRX Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, MGRX has a market cap of 9M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while MGRX trades at $0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas MGRX's P/E ratio is -0.39. In terms of profitability, IMS's ROE is +0.27%, compared to MGRX's ROE of -1.21%. Regarding short-term risk, IMS is less volatile compared to MGRX. This indicates lower risk in terms of short-term price fluctuations for IMS.Check MGRX's competition here
UpHealth, Inc. (NYSE: UPH)
IMS vs UPH Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas UPH's P/E ratio is -0.07. In terms of profitability, IMS's ROE is +0.27%, compared to UPH's ROE of -1.05%. Regarding short-term risk, IMS is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for IMS.Check UPH's competition here
UpHealth, Inc. (NYSE: UPH-WT)
IMS vs UPH-WT Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, IMS's ROE is +0.27%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, IMS is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for IMS.Check UPH-WT's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
IMS vs PEARW Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas PEARW's P/E ratio is -0.00. In terms of profitability, IMS's ROE is +0.27%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, IMS is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for IMS.Check PEARW's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
IMS vs PEAR Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas PEAR's P/E ratio is -0.08. In terms of profitability, IMS's ROE is +0.27%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, IMS is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for IMS.Check PEAR's competition here
Ontrak, Inc. (NASDAQ: OTRK)
IMS vs OTRK Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas OTRK's P/E ratio is -0.02. In terms of profitability, IMS's ROE is +0.27%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, IMS is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for IMS.Check OTRK's competition here
CareMax, Inc. (NASDAQ: CMAX)
IMS vs CMAX Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas CMAX's P/E ratio is -0.00. In terms of profitability, IMS's ROE is +0.27%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, IMS is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for IMS.Check CMAX's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
IMS vs HCTI Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, HCTI has a market cap of 1.4M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while HCTI trades at $1.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas HCTI's P/E ratio is -0.16. In terms of profitability, IMS's ROE is +0.27%, compared to HCTI's ROE of -0.68%. Regarding short-term risk, IMS is less volatile compared to HCTI. This indicates lower risk in terms of short-term price fluctuations for IMS.Check HCTI's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
IMS vs VSEEW Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, VSEEW has a market cap of 1.4M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while VSEEW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, IMS's ROE is +0.27%, compared to VSEEW's ROE of -115.71%. Regarding short-term risk, IMS is less volatile compared to VSEEW. This indicates lower risk in terms of short-term price fluctuations for IMS.Check VSEEW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
IMS vs LIFWZ Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, IMS's ROE is +0.27%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, IMS is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for IMS.Check LIFWZ's competition here
Aclarion, Inc. (NASDAQ: ACON)
IMS vs ACON Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, ACON has a market cap of 1.2M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while ACON trades at $2.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas ACON's P/E ratio is -0.25. In terms of profitability, IMS's ROE is +0.27%, compared to ACON's ROE of -0.59%. Regarding short-term risk, IMS is less volatile compared to ACON. This indicates lower risk in terms of short-term price fluctuations for IMS.Check ACON's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
IMS vs EUDAW Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, EUDAW has a market cap of 1.1M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while EUDAW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas EUDAW's P/E ratio is 0.04. In terms of profitability, IMS's ROE is +0.27%, compared to EUDAW's ROE of +1.20%. Regarding short-term risk, IMS is less volatile compared to EUDAW. This indicates lower risk in terms of short-term price fluctuations for IMS.Check EUDAW's competition here
VSee Health, Inc. (NASDAQ: VSEE)
IMS vs VSEE Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, VSEE has a market cap of 816.5K. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while VSEE trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas VSEE's P/E ratio is -0.10. In terms of profitability, IMS's ROE is +0.27%, compared to VSEE's ROE of -115.71%. Regarding short-term risk, IMS is less volatile compared to VSEE. This indicates lower risk in terms of short-term price fluctuations for IMS.Check VSEE's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
IMS vs MSPRZ Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, IMS's ROE is +0.27%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, IMS is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for IMS.Check MSPRZ's competition here
Akerna Corp. (NASDAQ: KERNW)
IMS vs KERNW Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas KERNW's P/E ratio is -0.00. In terms of profitability, IMS's ROE is +0.27%, compared to KERNW's ROE of -0.20%. Regarding short-term risk, IMS is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for IMS.Check KERNW's competition here
Akerna Corp. (NASDAQ: KERN)
IMS vs KERN Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas KERN's P/E ratio is -0.01. In terms of profitability, IMS's ROE is +0.27%, compared to KERN's ROE of -0.20%. Regarding short-term risk, IMS is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for IMS.Check KERN's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
IMS vs LIFWW Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas LIFWW's P/E ratio is N/A. In terms of profitability, IMS's ROE is +0.27%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, IMS is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for IMS.Check LIFWW's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
IMS vs ZCMD Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, ZCMD has a market cap of 37.2K. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while ZCMD trades at $1.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas ZCMD's P/E ratio is -0.04. In terms of profitability, IMS's ROE is +0.27%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, IMS is less volatile compared to ZCMD. This indicates lower risk in terms of short-term price fluctuations for IMS.Check ZCMD's competition here
CareMax, Inc. (NASDAQ: CMAXW)
IMS vs CMAXW Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas CMAXW's P/E ratio is N/A. In terms of profitability, IMS's ROE is +0.27%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, IMS is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for IMS.Check CMAXW's competition here
Aclarion, Inc. (NASDAQ: ACONW)
IMS vs ACONW Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, ACONW has a market cap of 13.1K. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while ACONW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas ACONW's P/E ratio is N/A. In terms of profitability, IMS's ROE is +0.27%, compared to ACONW's ROE of -0.59%. Regarding short-term risk, IMS is more volatile compared to ACONW. This indicates higher risk in terms of short-term price fluctuations for IMS.Check ACONW's competition here
GeneDx Holdings Corp. (NASDAQ: WGSWW)
IMS vs WGSWW Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, WGSWW has a market cap of 5.8K. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while WGSWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas WGSWW's P/E ratio is -0.00. In terms of profitability, IMS's ROE is +0.27%, compared to WGSWW's ROE of -0.39%. Regarding short-term risk, IMS is more volatile compared to WGSWW. This indicates higher risk in terms of short-term price fluctuations for IMS.Check WGSWW's competition here
CareCloud, Inc. (NASDAQ: MTBC)
IMS vs MTBC Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, MTBC has a market cap of 0. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas MTBC's P/E ratio is N/A. In terms of profitability, IMS's ROE is +0.27%, compared to MTBC's ROE of +0.19%. Regarding short-term risk, IMS is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for IMS.Check MTBC's competition here
Alkuri Global Acquisition Corp. (NASDAQ: KURIU)
IMS vs KURIU Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, KURIU has a market cap of 0. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while KURIU trades at $9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas KURIU's P/E ratio is N/A. In terms of profitability, IMS's ROE is +0.27%, compared to KURIU's ROE of +1.06%. Regarding short-term risk, IMS is less volatile compared to KURIU. This indicates lower risk in terms of short-term price fluctuations for IMS.Check KURIU's competition here
MSP Recovery, Inc. (NASDAQ: MSPRV)
IMS vs MSPRV Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while MSPRV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas MSPRV's P/E ratio is N/A. In terms of profitability, IMS's ROE is +0.27%, compared to MSPRV's ROE of N/A. Regarding short-term risk, IMS is less volatile compared to MSPRV. This indicates lower risk in terms of short-term price fluctuations for IMS.Check MSPRV's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
IMS vs MTBCP Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas MTBCP's P/E ratio is N/A. In terms of profitability, IMS's ROE is +0.27%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, IMS is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for IMS.Check MTBCP's competition here
Sema4 Holdings Corp. (NASDAQ: SMFRW)
IMS vs SMFRW Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while SMFRW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas SMFRW's P/E ratio is N/A. In terms of profitability, IMS's ROE is +0.27%, compared to SMFRW's ROE of -0.39%. Regarding short-term risk, IMS is less volatile compared to SMFRW. This indicates lower risk in terms of short-term price fluctuations for IMS.Check SMFRW's competition here
Affymetrix, Inc. (NASDAQ: AFFX)
IMS vs AFFX Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, AFFX has a market cap of 0. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while AFFX trades at $14.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas AFFX's P/E ratio is N/A. In terms of profitability, IMS's ROE is +0.27%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, IMS is more volatile compared to AFFX. This indicates higher risk in terms of short-term price fluctuations for IMS.Check AFFX's competition here
Nava Health MD, LLC (NASDAQ: NAVA)
IMS vs NAVA Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, NAVA has a market cap of 0. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while NAVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas NAVA's P/E ratio is N/A. In terms of profitability, IMS's ROE is +0.27%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, IMS is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for IMS.Check NAVA's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
IMS vs CHNGU Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas CHNGU's P/E ratio is N/A. In terms of profitability, IMS's ROE is +0.27%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, IMS is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for IMS.Check CHNGU's competition here
NantHealth, Inc. (NASDAQ: NH)
IMS vs NH Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, NH has a market cap of 0. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas NH's P/E ratio is -0.12. In terms of profitability, IMS's ROE is +0.27%, compared to NH's ROE of +0.35%. Regarding short-term risk, IMS is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for IMS.Check NH's competition here
Cerner Corporation (NASDAQ: CERN)
IMS vs CERN Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, CERN has a market cap of 0. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while CERN trades at $94.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas CERN's P/E ratio is 55.84. In terms of profitability, IMS's ROE is +0.27%, compared to CERN's ROE of +0.14%. Regarding short-term risk, IMS is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for IMS.Check CERN's competition here
Castlight Health, Inc. (NYSE: CSLT)
IMS vs CSLT Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, CSLT has a market cap of 0. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while CSLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas CSLT's P/E ratio is -37.27. In terms of profitability, IMS's ROE is +0.27%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, IMS is more volatile compared to CSLT. This indicates higher risk in terms of short-term price fluctuations for IMS.Check CSLT's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
IMS vs MTBCO Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas MTBCO's P/E ratio is N/A. In terms of profitability, IMS's ROE is +0.27%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, IMS is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for IMS.Check MTBCO's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
IMS vs CHNG Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, CHNG has a market cap of 0. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas CHNG's P/E ratio is -152.72. In terms of profitability, IMS's ROE is +0.27%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, IMS is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for IMS.Check CHNG's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
IMS vs CNVY Comparison August 2026
IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMS stands at 0. In comparison, CNVY has a market cap of 0. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMS currently has a P/E ratio of N/A, whereas CNVY's P/E ratio is -71.50. In terms of profitability, IMS's ROE is +0.27%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, IMS is more volatile compared to CNVY. This indicates higher risk in terms of short-term price fluctuations for IMS.Check CNVY's competition here